Transfection Reagents and Equipment Market By Product (Reagent, and Instrument), By Method (Biochemical, Gene Expression Studies, Cancer Research, Transgenic Model, Physical, and Viral), By Application (Biomedical Research, Protein Production, and Therapeutic Delivery), By End-User and By Geography – Global Drivers, Restraints, Opportunities, Trends, and Forecast up to 2026
Transfection is a procedure of presenting hereditary material, for example, DNA or RNA, into eukaryotic cells to empower the creation or articulation of proteins utilizing the cell's own apparatus. An RNA transfection with two complementary strands is engaged to terminate the production of some proteins by restricting the conversion procedure. The procedure of transfection allows the study of gene functioning and expression, genetic mutations, and protein functioning.
Furthermore, in recent times, the biopharmaceutical industry has witnessed a significant patent cliff as several potential biologics are facing patent expiration. Consequently, several companies have shifted their investments in the production of biosimilar alternatives to off-patent biologics and to overcome the threat of revenue loss. Hence, this emerging patent cliff threat has significantly benefitted the market by the high adoption of transfection technology.
Research Methodology:
The transfection reagents and equipment market has been analyzed by utilizing the optimum combination of secondary sources and in-house methodology, along with an irreplaceable blend of primary insights. The real-time assessment of the market is an integral part of our market sizing and forecasting methodology. Our industry experts and panel of primary participants have helped in compiling relevant aspects with realistic parametric estimations for a comprehensive study. The participation share of different categories of primary participants is given below:
Technological advancements to introduce the enhanced techniques for stable and transient transfection with negligible off-target effects are projected to obtain high results in the market during the forecast period. For instance, Life Technologies has introduced Lipofectamine, a lipid-based formulation for nucleic acid delivery, which intensifies cells capable of survivability and reproducibility throughout the transfection process of hard to transfect cell lines by optimization in different steps of transfection.
The transfection reagents and equipment market was valued at $960.13 million in 2020, and is projected to reach $1,496.43 million by 2026, growing at a CAGR of 7.7% during the forecast period.
The scope of the Transfection Reagents and Equipment Market is defined in the market analysis as follows:
Asia-Pacific is predicted to register the rapid growth in the forecast period. Significant factors driving the growth of the regional market are the growing number of biopharmaceutical & clinical R&D programs, increasing medical research expenditure, rising awareness regarding cytological and proteomic expressions.
The report also includes the analysis of major players in the Transfection Reagents and Equipment market. Some of the major players consist of Thermo Fisher Scientific Inc, PROMEGA CORPORATION, Lonza Group Ltd, Qiagen N.V, Bio–Rad Laboratories, Inc, Maxcyte, Inc, Merck KGaA, Polyplus-Transfection Sa, F. Hoffmann-La Roche Ltd, and Mirus Bio LLC.
The present trends of the market, dynamics of the market, and dynamic requirements of the end-users are provided in this study to assist the market vendor. The user experience is intensified by the Transfection Reagents and Equipment market report’s analysis based on qualitative and quantitative.
Furthermore, in recent times, the biopharmaceutical industry has witnessed a significant patent cliff as several potential biologics are facing patent expiration. Consequently, several companies have shifted their investments in the production of biosimilar alternatives to off-patent biologics and to overcome the threat of revenue loss. Hence, this emerging patent cliff threat has significantly benefitted the market by the high adoption of transfection technology.
Research Methodology:
The transfection reagents and equipment market has been analyzed by utilizing the optimum combination of secondary sources and in-house methodology, along with an irreplaceable blend of primary insights. The real-time assessment of the market is an integral part of our market sizing and forecasting methodology. Our industry experts and panel of primary participants have helped in compiling relevant aspects with realistic parametric estimations for a comprehensive study. The participation share of different categories of primary participants is given below:
Technological advancements to introduce the enhanced techniques for stable and transient transfection with negligible off-target effects are projected to obtain high results in the market during the forecast period. For instance, Life Technologies has introduced Lipofectamine, a lipid-based formulation for nucleic acid delivery, which intensifies cells capable of survivability and reproducibility throughout the transfection process of hard to transfect cell lines by optimization in different steps of transfection.
The transfection reagents and equipment market was valued at $960.13 million in 2020, and is projected to reach $1,496.43 million by 2026, growing at a CAGR of 7.7% during the forecast period.
The scope of the Transfection Reagents and Equipment Market is defined in the market analysis as follows:
- Based on Product
- Reagents
- Instruments
- Based on Method
- Biochemical
- Calcium Phosphate
- Lipofection
- DEAE-dextran
- Dendrimers
- Physical
- Electroporation
- Nucleofection
- Others (Genegun, Sonoporation, Magnetofection, and Optoinjection)
- Viral
- Based on Application
- Biomedical Research
- Gene Expression Studies
- Cancer Research
- Transgenic Model
- Protein Production
- Therapeutic Delivery
- Based on End-User
- Academic & Research Institutes
- Pharmaceutical & Biotechnology Companies
- Based on Geography:
- North America
- Europe
- Asia Pacific
- Rest of World
Asia-Pacific is predicted to register the rapid growth in the forecast period. Significant factors driving the growth of the regional market are the growing number of biopharmaceutical & clinical R&D programs, increasing medical research expenditure, rising awareness regarding cytological and proteomic expressions.
The report also includes the analysis of major players in the Transfection Reagents and Equipment market. Some of the major players consist of Thermo Fisher Scientific Inc, PROMEGA CORPORATION, Lonza Group Ltd, Qiagen N.V, Bio–Rad Laboratories, Inc, Maxcyte, Inc, Merck KGaA, Polyplus-Transfection Sa, F. Hoffmann-La Roche Ltd, and Mirus Bio LLC.
The present trends of the market, dynamics of the market, and dynamic requirements of the end-users are provided in this study to assist the market vendor. The user experience is intensified by the Transfection Reagents and Equipment market report’s analysis based on qualitative and quantitative.
- The competitive analysis of the major players enables users to understand the dynamic strategies such as product innovation, partnerships, merger & acquisitions, and joint ventures of the key players
- This report also provides the portfolio analysis, capability analysis of the leading players
- Quantitative analysis of the market enables users to understand the facts of the market across four major regions
1. EXECUTIVE SUMMARY
2. METHOD OUTLOOK
2.1. METHOD Overview
2.2. METHOD Trends
3. MARKET SNAPSHOT
3.1. Total Adressable Market
3.2. Segment Addressable Market
3.2.1. PEST Analysis
3.2.2. Porter Five Forces
3.3. Related Markets
3.4. Ecosystem
4. MARKET OUTLOOK
4.1. Overview
4.1.1. Market Evolution
4.2. Market Trends and Impact
4.3. Pricing Analysis
4.4. Market Segmentation
4.5. Market Dynamics
4.5.1. Drivers
4.5.2. Restraints
4.5.3. Opportunities
4.6. DRO - Impact Analysis
5. PRODUCT: MARKET SIZE & ANALYSIS
5.1. Overview
5.2. Reagents
5.3. Instruments
6. APPLICATION: MARKET SIZE & ANALYSIS
6.1. Overview
6.2. Biomedical Research
6.2.1. Gene Expression Studies
6.2.2. Cancer Research
6.2.3. Transgenic Model
6.3. Protein Production
6.4. Therapeutic Deli very
7. METHOD: MARKET SIZE & ANALYSIS
7.1. Overview
7.2. Biochemical
7.2.1. Calcium Phosphate
7.2.2. Lipofection
7.2.3. DEAE-dextran
7.2.4. Dendrimers
7.3. Physical
7.3.1. Electroporation
7.3.2. Nucleofection
7.3.3. Others
7.4. Viral
8. END-USER: MARKET SIZE & ANALYSIS
8.1. Overview
8.2. Academic & Research Institutes
8.3. Pharmaceutical & Biotechnology Companies
9. GEOGRAPHY: MARKET SIZE & ANALYSIS
9.1. Overview
9.2. North America
9.3. Europe
9.4. Asia Pacific
9.5. Rest of the World
10. COMPETITIVE LANDSCAPE
10.1. Competitor Comparison Analysis
10.2. Market Developments
10.2.1. Mergers and Acquisitions, Legal, Awards, Partnerships
10.2.2. Product Launches and execution
11. VENDOR PROFILES
11.1. Thermo Fisher Scientific Inc
11.1.1. Overview
11.1.2. Business Units
11.1.3. Geographic Revenue
11.1.4. Product Offerings
11.1.5. Developments
11.1.6. Business Strategy
11.2. Promega Corporation
11.2.1. Overview
11.2.2. Business Units
11.2.3. Geographic Revenue
11.2.4. Product Offerings
11.2.5. Developments
11.2.6. Business Strategy
11.3. Lonza Group Ltd
11.3.1. Overview
11.3.2. Business Units
11.3.3. Geographic Revenue
11.3.4. Product Offerings
11.3.5. Developments
11.3.6. Business Strategy
11.4. Qiagen N.V
11.4.1. Overview
11.4.2. Business Units
11.4.3. Geographic Revenue
11.4.4. Product Offerings
11.4.5. Developments
11.4.6. Business Strategy
11.5. Bio–Rad Laboratories, Inc
11.5.1. Overview
11.5.2. Business Units
11.5.3. Geographic Revenue
11.5.4. Product Offerings
11.5.5. Developments
11.5.6. Business Strategy
11.6. Maxcyte, Inc
11.6.1. Overview
11.6.2. Business Units
11.6.3. Geographic Revenue
11.6.4. Product Offerings
11.6.5. Developments
11.6.6. Business Strategy
11.7. Merck KGaA
11.7.1. Overview
11.7.2. Business Units
11.7.3. Geographic Revenue
11.7.4. Product Offerings
11.7.5. Developments
11.7.6. Business Strategy
11.8. Polyplus-Transfection Sa
11.8.1. Overview
11.8.2. Business Units
11.8.3. Geographic Revenue
11.8.4. Product Offerings
11.8.5. Developments
11.8.6. Business Strategy
11.9. F. Hoffmann-La Roche Ltd
11.9.1. Overview
11.9.2. Business Units
11.9.3. Geographic Revenue
11.9.4. Product Offerings
11.9.5. Developments
11.9.6. Business Strategy
11.10. Mirus Bio LLC.
11.10.1. Overview
11.10.2. Business Units
11.10.3. Geographic Revenue
11.10.4. Product Offerings
11.10.5. Developments
11.10.6. Business Strategy
11.10.7.
12. ANALYST OPINION
13. ANNEXURE
13.1. Report Scope
13.2. Market Definitions
13.3. Research Methodology
13.3.1. Data Collation and In-house Estimation
13.3.2. Market Triangulation
13.3.3. Forecasting
13.4. Report Assumptions
13.5. Declarations
13.6. Stakeholders
13.7. Abbreviations
2. METHOD OUTLOOK
2.1. METHOD Overview
2.2. METHOD Trends
3. MARKET SNAPSHOT
3.1. Total Adressable Market
3.2. Segment Addressable Market
3.2.1. PEST Analysis
3.2.2. Porter Five Forces
3.3. Related Markets
3.4. Ecosystem
4. MARKET OUTLOOK
4.1. Overview
4.1.1. Market Evolution
4.2. Market Trends and Impact
4.3. Pricing Analysis
4.4. Market Segmentation
4.5. Market Dynamics
4.5.1. Drivers
4.5.2. Restraints
4.5.3. Opportunities
4.6. DRO - Impact Analysis
5. PRODUCT: MARKET SIZE & ANALYSIS
5.1. Overview
5.2. Reagents
5.3. Instruments
6. APPLICATION: MARKET SIZE & ANALYSIS
6.1. Overview
6.2. Biomedical Research
6.2.1. Gene Expression Studies
6.2.2. Cancer Research
6.2.3. Transgenic Model
6.3. Protein Production
6.4. Therapeutic Deli very
7. METHOD: MARKET SIZE & ANALYSIS
7.1. Overview
7.2. Biochemical
7.2.1. Calcium Phosphate
7.2.2. Lipofection
7.2.3. DEAE-dextran
7.2.4. Dendrimers
7.3. Physical
7.3.1. Electroporation
7.3.2. Nucleofection
7.3.3. Others
7.4. Viral
8. END-USER: MARKET SIZE & ANALYSIS
8.1. Overview
8.2. Academic & Research Institutes
8.3. Pharmaceutical & Biotechnology Companies
9. GEOGRAPHY: MARKET SIZE & ANALYSIS
9.1. Overview
9.2. North America
9.3. Europe
9.4. Asia Pacific
9.5. Rest of the World
10. COMPETITIVE LANDSCAPE
10.1. Competitor Comparison Analysis
10.2. Market Developments
10.2.1. Mergers and Acquisitions, Legal, Awards, Partnerships
10.2.2. Product Launches and execution
11. VENDOR PROFILES
11.1. Thermo Fisher Scientific Inc
11.1.1. Overview
11.1.2. Business Units
11.1.3. Geographic Revenue
11.1.4. Product Offerings
11.1.5. Developments
11.1.6. Business Strategy
11.2. Promega Corporation
11.2.1. Overview
11.2.2. Business Units
11.2.3. Geographic Revenue
11.2.4. Product Offerings
11.2.5. Developments
11.2.6. Business Strategy
11.3. Lonza Group Ltd
11.3.1. Overview
11.3.2. Business Units
11.3.3. Geographic Revenue
11.3.4. Product Offerings
11.3.5. Developments
11.3.6. Business Strategy
11.4. Qiagen N.V
11.4.1. Overview
11.4.2. Business Units
11.4.3. Geographic Revenue
11.4.4. Product Offerings
11.4.5. Developments
11.4.6. Business Strategy
11.5. Bio–Rad Laboratories, Inc
11.5.1. Overview
11.5.2. Business Units
11.5.3. Geographic Revenue
11.5.4. Product Offerings
11.5.5. Developments
11.5.6. Business Strategy
11.6. Maxcyte, Inc
11.6.1. Overview
11.6.2. Business Units
11.6.3. Geographic Revenue
11.6.4. Product Offerings
11.6.5. Developments
11.6.6. Business Strategy
11.7. Merck KGaA
11.7.1. Overview
11.7.2. Business Units
11.7.3. Geographic Revenue
11.7.4. Product Offerings
11.7.5. Developments
11.7.6. Business Strategy
11.8. Polyplus-Transfection Sa
11.8.1. Overview
11.8.2. Business Units
11.8.3. Geographic Revenue
11.8.4. Product Offerings
11.8.5. Developments
11.8.6. Business Strategy
11.9. F. Hoffmann-La Roche Ltd
11.9.1. Overview
11.9.2. Business Units
11.9.3. Geographic Revenue
11.9.4. Product Offerings
11.9.5. Developments
11.9.6. Business Strategy
11.10. Mirus Bio LLC.
11.10.1. Overview
11.10.2. Business Units
11.10.3. Geographic Revenue
11.10.4. Product Offerings
11.10.5. Developments
11.10.6. Business Strategy
11.10.7.
12. ANALYST OPINION
13. ANNEXURE
13.1. Report Scope
13.2. Market Definitions
13.3. Research Methodology
13.3.1. Data Collation and In-house Estimation
13.3.2. Market Triangulation
13.3.3. Forecasting
13.4. Report Assumptions
13.5. Declarations
13.6. Stakeholders
13.7. Abbreviations
LIST OF TABLES
TABLE 1. GLOBAL TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, BY PRODUCT, 2020-2026 (USD MILLION)
TABLE 2. GLOBAL TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE FOR REAGENTS, BY GEOGRAPHY, 2020-2026 (USD MILLION)
TABLE 3. GLOBAL TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE FOR EQUIPMENT, BY GEOGRAPHY, 2020-2026 (USD MILLION)
TABLE 4. GLOBAL TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, BY APPLICATION, 2020-2026 (USD MILLION)
TABLE 5. GLOBAL TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE FOR BIOMEDICAL RESEARCH, BY GEOGRAPHY, 2020-2026 (USD MILLION)
TABLE 6. GLOBAL TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE FOR GENE EXPRESSION STUDIES, BY GEOGRAPHY, 2020-2026 (USD MILLION)
TABLE 7. GLOBAL TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE FOR CANCER RESEARCH, BY GEOGRAPHY, 2020-2026 (USD MILLION)
TABLE 8. GLOBAL TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE FOR TRANSGENIC MODEL, BY GEOGRAPHY, 2020-2026 (USD MILLION)
TABLE 9. GLOBAL TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE FOR PROTEIN PRODUCTION, BY GEOGRAPHY, 2020-2026 (USD MILLION)
TABLE 10. GLOBAL TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE FOR THERAPEUTIC DELIVERY, BY GEOGRAPHY, 2020-2026 (USD MILLION)
TABLE 11. GLOBAL TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, BY METHOD, 2020-2026 (USD MILLION)
TABLE 12. GLOBAL TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE FOR BIOCHEMICAL, BY GEOGRAPHY, 2020-2026 (USD MILLION)
TABLE 13. GLOBAL TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE FOR CALCIUM PHOSPHATE, BY GEOGRAPHY, 2020-2026 (USD MILLION)
TABLE 14. GLOBAL TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE FOR LIPOFECTION, BY GEOGRAPHY, 2020-2026 (USD MILLION)
TABLE 15. GLOBAL TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE FOR DEAE-DEXTRAN, BY GEOGRAPHY, 2020-2026 (USD MILLION)
TABLE 16. GLOBAL TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE FOR DENDRIMERS, BY GEOGRAPHY, 2020-2026 (USD MILLION)
TABLE 17. GLOBAL TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE FOR PHYSICAL, BY GEOGRAPHY, 2020-2026 (USD MILLION)
TABLE 18. GLOBAL TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE FOR ELECTROPORATION, BY GEOGRAPHY, 2020-2026 (USD MILLION)
TABLE 19. GLOBAL TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE FOR NUCLEOFECTION, BY GEOGRAPHY, 2020-2026 (USD MILLION)
TABLE 20. GLOBAL TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE FOR OTHERS, BY GEOGRAPHY, 2020-2026 (USD MILLION)
TABLE 21. GLOBAL TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, BY END-USER, 2020-2026 (USD MILLION)
TABLE 22. GLOBAL TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE FOR ACADEMIC & RESEARCH INSTITUTES, BY GEOGRAPHY, 2020-2026 (USD MILLION)
TABLE 23. GLOBAL TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY GEOGRAPHY, 2020-2026 (USD MILLION)
TABLE 24. GLOBAL TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, BY GEOGRAPHY, 2020-2026 (USD MILLION)
TABLE 25. NORTH AMERICA TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, BY COUNTRY, 2020-2026 (USD MILLION)
TABLE 26. NORTH AMERICA TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, BY PRODUCT, 2020-2026 (USD MILLION)
TABLE 27. NORTH AMERICA TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, BY APPLICATION, 2020-2026 (USD MILLION)
TABLE 28. NORTH AMERICA TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, BY METHOD, 2020-2026 (USD MILLION)
TABLE 29. NORTH AMERICA TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, BY END-USER, 2020-2026 (USD MILLION)
TABLE 30. U.S TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, BY PRODUCT, 2020-2026 (USD MILLION)
TABLE 31. U.S TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, BY APPLICATION, 2020-2026 (USD MILLION)
TABLE 32. U.S TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, BY METHOD, 2020-2026 (USD MILLION)
TABLE 33. U.S TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, BY END-USER, 2020-2026 (USD MILLION)
TABLE 34. CANADA TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, BY PRODUCT, 2020-2026 (USD MILLION)
TABLE 35. CANADA TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, BY APPLICATION, 2020-2026 (USD MILLION)
TABLE 36. CANADA TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, BY METHOD, 2020-2026 (USD MILLION)
TABLE 37. CANADA TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, BY END-USER, 2020-2026 (USD MILLION)
TABLE 38. EUROPE TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, BY COUNTRY, 2020-2026 (USD MILLION)
TABLE 39. EUROPE TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, BY PRODUCT, 2020-2026 (USD MILLION)
TABLE 40. EUROPE TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, BY APPLICATION, 2020-2026 (USD MILLION)
TABLE 41. EUROPE TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, BY METHOD, 2020-2026 (USD MILLION)
TABLE 42. EUROPE TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, BY END-USER, 2020-2026 (USD MILLION)
TABLE 43. GERMANY TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, BY PRODUCT, 2020-2026 (USD MILLION)
TABLE 44. GERMANY TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, BY APPLICATION, 2020-2026 (USD MILLION)
TABLE 45. GERMANY TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, BY METHOD, 2020-2026 (USD MILLION)
TABLE 46. GERMANY TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, BY END-USER, 2020-2026 (USD MILLION)
TABLE 47. U.K TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, BY PRODUCT, 2020-2026 (USD MILLION)
TABLE 48. U.K TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, BY APPLICATION, 2020-2026 (USD MILLION)
TABLE 49. U.K TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, BY METHOD, 2020-2026 (USD MILLION)
TABLE 50. U.K TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, BY END-USER, 2020-2026 (USD MILLION)
TABLE 51. ROE TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, BY PRODUCT, 2020-2026 (USD MILLION)
TABLE 52. ROE TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, BY APPLICATION, 2020-2026 (USD MILLION)
TABLE 53. ROE TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, BY METHOD, 2020-2026 (USD MILLION)
TABLE 54. ROE TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, BY END-USER, 2020-2026 (USD MILLION)
TABLE 55. ASIA PACIFIC TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, BY COUNTRY, 2020-2026 (USD MILLION)
TABLE 56. ASIA PACIFIC TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, BY PRODUCT, 2020-2026 (USD MILLION)
TABLE 57. ASIA PACIFIC TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, BY APPLICATION, 2020-2026 (USD MILLION)
TABLE 58. ASIA PACIFIC TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, BY METHOD, 2020-2026 (USD MILLION)
TABLE 59. ASIA PACIFIC TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, BY END-USER, 2020-2026 (USD MILLION)
TABLE 60. CHINA TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, BY PRODUCT, 2020-2026 (USD MILLION)
TABLE 61. CHINA TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, BY APPLICATION, 2020-2026 (USD MILLION)
TABLE 62. CHINA TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, BY METHOD, 2020-2026 (USD MILLION)
TABLE 63. CHINA TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, BY END-USER, 2020-2026 (USD MILLION)
TABLE 64. JAPAN TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, BY PRODUCT, 2020-2026 (USD MILLION)
TABLE 65. JAPAN TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, BY APPLICATION, 2020-2026 (USD MILLION)
TABLE 66. JAPAN TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, BY METHOD, 2020-2026 (USD MILLION)
TABLE 67. JAPAN TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, BY END-USER, 2020-2026 (USD MILLION)
TABLE 68. REST OF ASIA PACIFIC TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, BY PRODUCT, 2020-2026 (USD MILLION)
TABLE 69. REST OF ASIA PACIFIC TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, BY APPLICATION, 2020-2026 (USD MILLION)
TABLE 70. REST OF ASIA PACIFIC TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, BY METHOD, 2020-2026 (USD MILLION)
TABLE 71. REST OF ASIA PACIFIC TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, BY END-USER, 2020-2026 (USD MILLION)
TABLE 72. REST OF WORLD TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, BY PRODUCT, 2020-2026 (USD MILLION)
TABLE 73. REST OF WORLD TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, BY APPLICATION, 2020-2026 (USD MILLION)
TABLE 74. REST OF WORLD TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, BY METHOD, 2020-2026 (USD MILLION)
TABLE 75. REST OF WORLD TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, BY END-USER, 2020-2026 (USD MILLION)
TABLE 76. THERMO FISHER SCIENTIFIC INC: OVERVIEW
TABLE 77. THERMO FISHER SCIENTIFIC INC: STRATEGIC SNAPSHOT
TABLE 78. THERMO FISHER SCIENTIFIC INC: BUSINESS OPPORTUNITIES AND OUTLOOK
TABLE 79. THERMO FISHER SCIENTIFIC INC: PRODUCT/SERVICE PORTFOLIO
TABLE 80. PROMEGA CORPORATION: OVERVIEW
TABLE 81. PROMEGA CORPORATION: STRATEGIC SNAPSHOT
TABLE 82. PROMEGA CORPORATION: BUSINESS OPPORTUNITIES AND OUTLOOK
TABLE 83. PROMEGA CORPORATION: PRODUCT/SERVICE PORTFOLIO
TABLE 84. LONZA GROUP LTD: OVERVIEW
TABLE 85. LONZA GROUP LTD: STRATEGIC SNAPSHOT
TABLE 86. LONZA GROUP LTD: BUSINESS OPPORTUNITIES AND OUTLOOK
TABLE 87. QIAGEN N.V: OVERVIEW
TABLE 88. QIAGEN N.V: STRATEGIC SNAPSHOT
TABLE 89. QIAGEN N.V: BUSINESS OPPORTUNITIES AND OUTLOOK
TABLE 90. QIAGEN N.V: PRODUCT/SERVICE PORTFOLIO
TABLE 91. BIO–RAD LABORATORIES, INC: OVERVIEW
TABLE 92. BIO–RAD LABORATORIES, INC: STRATEGIC SNAPSHOT
TABLE 93. BIO–RAD LABORATORIES, INC: BUSINESS OPPORTUNITIES AND OUTLOOK
TABLE 94. BIO–RAD LABORATORIES, INC: PRODUCT/SERVICE PORTFOLIO
TABLE 95. MAXCYTE, INC: OVERVIEW
TABLE 96. MAXCYTE, INC: STRATEGIC SNAPSHOT
TABLE 97. MAXCYTE, INC: BUSINESS OPPORTUNITIES AND OUTLOOK
TABLE 98. MAXCYTE, INC: PRODUCT/SERVICE PORTFOLIO
TABLE 99. MERCK KGAA: OVERVIEW
TABLE 100. MERCK KGAA: STRATEGIC SNAPSHOT
TABLE 101. MERCK KGAA: BUSINESS OPPORTUNITIES AND OUTLOOK
TABLE 102. MERCK KGAA: PRODUCT/SERVICE PORTFOLIO
TABLE 103. POLYPLUS-TRANSFECTION SA: OVERVIEW
TABLE 104. POLYPLUS-TRANSFECTION SA: STRATEGIC SNAPSHOT
TABLE 105. POLYPLUS-TRANSFECTION SA: BUSINESS OPPORTUNITIES AND OUTLOOK
TABLE 106. POLYPLUS-TRANSFECTION SA: PRODUCT/SERVICE PORTFOLIO
TABLE 107. MIRUS BIO LLC: OVERVIEW
TABLE 108. MIRUS BIO LLC: STRATEGIC SNAPSHOT
TABLE 109. MIRUS BIO LLC: BUSINESS OPPORTUNITIES AND OUTLOOK
TABLE 110. MIRUS BIO LLC: PRODUCT/SERVICE PORTFOLIO
TABLE 1. GLOBAL TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, BY PRODUCT, 2020-2026 (USD MILLION)
TABLE 2. GLOBAL TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE FOR REAGENTS, BY GEOGRAPHY, 2020-2026 (USD MILLION)
TABLE 3. GLOBAL TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE FOR EQUIPMENT, BY GEOGRAPHY, 2020-2026 (USD MILLION)
TABLE 4. GLOBAL TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, BY APPLICATION, 2020-2026 (USD MILLION)
TABLE 5. GLOBAL TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE FOR BIOMEDICAL RESEARCH, BY GEOGRAPHY, 2020-2026 (USD MILLION)
TABLE 6. GLOBAL TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE FOR GENE EXPRESSION STUDIES, BY GEOGRAPHY, 2020-2026 (USD MILLION)
TABLE 7. GLOBAL TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE FOR CANCER RESEARCH, BY GEOGRAPHY, 2020-2026 (USD MILLION)
TABLE 8. GLOBAL TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE FOR TRANSGENIC MODEL, BY GEOGRAPHY, 2020-2026 (USD MILLION)
TABLE 9. GLOBAL TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE FOR PROTEIN PRODUCTION, BY GEOGRAPHY, 2020-2026 (USD MILLION)
TABLE 10. GLOBAL TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE FOR THERAPEUTIC DELIVERY, BY GEOGRAPHY, 2020-2026 (USD MILLION)
TABLE 11. GLOBAL TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, BY METHOD, 2020-2026 (USD MILLION)
TABLE 12. GLOBAL TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE FOR BIOCHEMICAL, BY GEOGRAPHY, 2020-2026 (USD MILLION)
TABLE 13. GLOBAL TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE FOR CALCIUM PHOSPHATE, BY GEOGRAPHY, 2020-2026 (USD MILLION)
TABLE 14. GLOBAL TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE FOR LIPOFECTION, BY GEOGRAPHY, 2020-2026 (USD MILLION)
TABLE 15. GLOBAL TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE FOR DEAE-DEXTRAN, BY GEOGRAPHY, 2020-2026 (USD MILLION)
TABLE 16. GLOBAL TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE FOR DENDRIMERS, BY GEOGRAPHY, 2020-2026 (USD MILLION)
TABLE 17. GLOBAL TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE FOR PHYSICAL, BY GEOGRAPHY, 2020-2026 (USD MILLION)
TABLE 18. GLOBAL TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE FOR ELECTROPORATION, BY GEOGRAPHY, 2020-2026 (USD MILLION)
TABLE 19. GLOBAL TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE FOR NUCLEOFECTION, BY GEOGRAPHY, 2020-2026 (USD MILLION)
TABLE 20. GLOBAL TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE FOR OTHERS, BY GEOGRAPHY, 2020-2026 (USD MILLION)
TABLE 21. GLOBAL TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, BY END-USER, 2020-2026 (USD MILLION)
TABLE 22. GLOBAL TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE FOR ACADEMIC & RESEARCH INSTITUTES, BY GEOGRAPHY, 2020-2026 (USD MILLION)
TABLE 23. GLOBAL TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY GEOGRAPHY, 2020-2026 (USD MILLION)
TABLE 24. GLOBAL TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, BY GEOGRAPHY, 2020-2026 (USD MILLION)
TABLE 25. NORTH AMERICA TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, BY COUNTRY, 2020-2026 (USD MILLION)
TABLE 26. NORTH AMERICA TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, BY PRODUCT, 2020-2026 (USD MILLION)
TABLE 27. NORTH AMERICA TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, BY APPLICATION, 2020-2026 (USD MILLION)
TABLE 28. NORTH AMERICA TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, BY METHOD, 2020-2026 (USD MILLION)
TABLE 29. NORTH AMERICA TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, BY END-USER, 2020-2026 (USD MILLION)
TABLE 30. U.S TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, BY PRODUCT, 2020-2026 (USD MILLION)
TABLE 31. U.S TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, BY APPLICATION, 2020-2026 (USD MILLION)
TABLE 32. U.S TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, BY METHOD, 2020-2026 (USD MILLION)
TABLE 33. U.S TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, BY END-USER, 2020-2026 (USD MILLION)
TABLE 34. CANADA TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, BY PRODUCT, 2020-2026 (USD MILLION)
TABLE 35. CANADA TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, BY APPLICATION, 2020-2026 (USD MILLION)
TABLE 36. CANADA TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, BY METHOD, 2020-2026 (USD MILLION)
TABLE 37. CANADA TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, BY END-USER, 2020-2026 (USD MILLION)
TABLE 38. EUROPE TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, BY COUNTRY, 2020-2026 (USD MILLION)
TABLE 39. EUROPE TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, BY PRODUCT, 2020-2026 (USD MILLION)
TABLE 40. EUROPE TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, BY APPLICATION, 2020-2026 (USD MILLION)
TABLE 41. EUROPE TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, BY METHOD, 2020-2026 (USD MILLION)
TABLE 42. EUROPE TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, BY END-USER, 2020-2026 (USD MILLION)
TABLE 43. GERMANY TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, BY PRODUCT, 2020-2026 (USD MILLION)
TABLE 44. GERMANY TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, BY APPLICATION, 2020-2026 (USD MILLION)
TABLE 45. GERMANY TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, BY METHOD, 2020-2026 (USD MILLION)
TABLE 46. GERMANY TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, BY END-USER, 2020-2026 (USD MILLION)
TABLE 47. U.K TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, BY PRODUCT, 2020-2026 (USD MILLION)
TABLE 48. U.K TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, BY APPLICATION, 2020-2026 (USD MILLION)
TABLE 49. U.K TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, BY METHOD, 2020-2026 (USD MILLION)
TABLE 50. U.K TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, BY END-USER, 2020-2026 (USD MILLION)
TABLE 51. ROE TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, BY PRODUCT, 2020-2026 (USD MILLION)
TABLE 52. ROE TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, BY APPLICATION, 2020-2026 (USD MILLION)
TABLE 53. ROE TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, BY METHOD, 2020-2026 (USD MILLION)
TABLE 54. ROE TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, BY END-USER, 2020-2026 (USD MILLION)
TABLE 55. ASIA PACIFIC TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, BY COUNTRY, 2020-2026 (USD MILLION)
TABLE 56. ASIA PACIFIC TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, BY PRODUCT, 2020-2026 (USD MILLION)
TABLE 57. ASIA PACIFIC TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, BY APPLICATION, 2020-2026 (USD MILLION)
TABLE 58. ASIA PACIFIC TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, BY METHOD, 2020-2026 (USD MILLION)
TABLE 59. ASIA PACIFIC TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, BY END-USER, 2020-2026 (USD MILLION)
TABLE 60. CHINA TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, BY PRODUCT, 2020-2026 (USD MILLION)
TABLE 61. CHINA TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, BY APPLICATION, 2020-2026 (USD MILLION)
TABLE 62. CHINA TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, BY METHOD, 2020-2026 (USD MILLION)
TABLE 63. CHINA TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, BY END-USER, 2020-2026 (USD MILLION)
TABLE 64. JAPAN TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, BY PRODUCT, 2020-2026 (USD MILLION)
TABLE 65. JAPAN TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, BY APPLICATION, 2020-2026 (USD MILLION)
TABLE 66. JAPAN TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, BY METHOD, 2020-2026 (USD MILLION)
TABLE 67. JAPAN TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, BY END-USER, 2020-2026 (USD MILLION)
TABLE 68. REST OF ASIA PACIFIC TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, BY PRODUCT, 2020-2026 (USD MILLION)
TABLE 69. REST OF ASIA PACIFIC TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, BY APPLICATION, 2020-2026 (USD MILLION)
TABLE 70. REST OF ASIA PACIFIC TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, BY METHOD, 2020-2026 (USD MILLION)
TABLE 71. REST OF ASIA PACIFIC TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, BY END-USER, 2020-2026 (USD MILLION)
TABLE 72. REST OF WORLD TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, BY PRODUCT, 2020-2026 (USD MILLION)
TABLE 73. REST OF WORLD TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, BY APPLICATION, 2020-2026 (USD MILLION)
TABLE 74. REST OF WORLD TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, BY METHOD, 2020-2026 (USD MILLION)
TABLE 75. REST OF WORLD TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, BY END-USER, 2020-2026 (USD MILLION)
TABLE 76. THERMO FISHER SCIENTIFIC INC: OVERVIEW
TABLE 77. THERMO FISHER SCIENTIFIC INC: STRATEGIC SNAPSHOT
TABLE 78. THERMO FISHER SCIENTIFIC INC: BUSINESS OPPORTUNITIES AND OUTLOOK
TABLE 79. THERMO FISHER SCIENTIFIC INC: PRODUCT/SERVICE PORTFOLIO
TABLE 80. PROMEGA CORPORATION: OVERVIEW
TABLE 81. PROMEGA CORPORATION: STRATEGIC SNAPSHOT
TABLE 82. PROMEGA CORPORATION: BUSINESS OPPORTUNITIES AND OUTLOOK
TABLE 83. PROMEGA CORPORATION: PRODUCT/SERVICE PORTFOLIO
TABLE 84. LONZA GROUP LTD: OVERVIEW
TABLE 85. LONZA GROUP LTD: STRATEGIC SNAPSHOT
TABLE 86. LONZA GROUP LTD: BUSINESS OPPORTUNITIES AND OUTLOOK
TABLE 87. QIAGEN N.V: OVERVIEW
TABLE 88. QIAGEN N.V: STRATEGIC SNAPSHOT
TABLE 89. QIAGEN N.V: BUSINESS OPPORTUNITIES AND OUTLOOK
TABLE 90. QIAGEN N.V: PRODUCT/SERVICE PORTFOLIO
TABLE 91. BIO–RAD LABORATORIES, INC: OVERVIEW
TABLE 92. BIO–RAD LABORATORIES, INC: STRATEGIC SNAPSHOT
TABLE 93. BIO–RAD LABORATORIES, INC: BUSINESS OPPORTUNITIES AND OUTLOOK
TABLE 94. BIO–RAD LABORATORIES, INC: PRODUCT/SERVICE PORTFOLIO
TABLE 95. MAXCYTE, INC: OVERVIEW
TABLE 96. MAXCYTE, INC: STRATEGIC SNAPSHOT
TABLE 97. MAXCYTE, INC: BUSINESS OPPORTUNITIES AND OUTLOOK
TABLE 98. MAXCYTE, INC: PRODUCT/SERVICE PORTFOLIO
TABLE 99. MERCK KGAA: OVERVIEW
TABLE 100. MERCK KGAA: STRATEGIC SNAPSHOT
TABLE 101. MERCK KGAA: BUSINESS OPPORTUNITIES AND OUTLOOK
TABLE 102. MERCK KGAA: PRODUCT/SERVICE PORTFOLIO
TABLE 103. POLYPLUS-TRANSFECTION SA: OVERVIEW
TABLE 104. POLYPLUS-TRANSFECTION SA: STRATEGIC SNAPSHOT
TABLE 105. POLYPLUS-TRANSFECTION SA: BUSINESS OPPORTUNITIES AND OUTLOOK
TABLE 106. POLYPLUS-TRANSFECTION SA: PRODUCT/SERVICE PORTFOLIO
TABLE 107. MIRUS BIO LLC: OVERVIEW
TABLE 108. MIRUS BIO LLC: STRATEGIC SNAPSHOT
TABLE 109. MIRUS BIO LLC: BUSINESS OPPORTUNITIES AND OUTLOOK
TABLE 110. MIRUS BIO LLC: PRODUCT/SERVICE PORTFOLIO
LIST OF FIGURES
CHART. 1. GLOBAL TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, BY PRODUCT, 2020-2026 (USD MILLION)
CHART. 2. GLOBAL TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE FOR REAGENTS, BY GEOGRAPHY, 2020-2026 (USD MILLION)
CHART. 3. GLOBAL TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE FOR EQUIPMENT, BY GEOGRAPHY, 2020-2026 (USD MILLION)
CHART. 4. GLOBAL TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, BY APPLICATION, 2020-2026 (USD MILLION)
CHART. 5. GLOBAL TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE FOR BIOMEDICAL RESEARCH, BY GEOGRAPHY, 2020-2026 (USD MILLION)
CHART. 6. GLOBAL TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE FOR GENE EXPRESSION STUDIES, BY GEOGRAPHY, 2020-2026 (USD MILLION)
CHART. 7. GLOBAL TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE FOR CANCER RESEARCH, BY GEOGRAPHY, 2020-2026 (USD MILLION)
CHART. 8. GLOBAL TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE FOR TRANSGENIC MODEL, BY GEOGRAPHY, 2020-2026 (USD MILLION)
CHART. 9. GLOBAL TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE FOR PROTEIN PRODUCTION, BY GEOGRAPHY, 2020-2026 (USD MILLION)
CHART. 10. GLOBAL TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE FOR THERAPEUTIC DELIVERY, BY GEOGRAPHY, 2020-2026 (USD MILLION)
CHART. 11. GLOBAL TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, BY METHOD, 2020-2026 (USD MILLION)
CHART. 12. GLOBAL TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE FOR BIOCHEMICAL, BY GEOGRAPHY, 2020-2026 (USD MILLION)
CHART. 13. GLOBAL TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE FOR CALCIUM PHOSPHATE, BY GEOGRAPHY, 2020-2026 (USD MILLION)
CHART. 14. GLOBAL TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE FOR LIPOFECTION, BY GEOGRAPHY, 2020-2026 (USD MILLION)
CHART. 15. GLOBAL TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE FOR DEAE-DEXTRAN, BY GEOGRAPHY, 2020-2026 (USD MILLION)
CHART. 16. GLOBAL TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE FOR DENDRIMERS, BY GEOGRAPHY, 2020-2026 (USD MILLION)
CHART. 17. GLOBAL TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE FOR PHYSICAL, BY GEOGRAPHY, 2020-2026 (USD MILLION)
CHART. 18. GLOBAL TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE FOR ELECTROPORATION, BY GEOGRAPHY, 2020-2026 (USD MILLION)
CHART. 19. GLOBAL TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE FOR NUCLEOFECTION, BY GEOGRAPHY, 2020-2026 (USD MILLION)
CHART. 20. GLOBAL TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE FOR OTHERS, BY GEOGRAPHY, 2020-2026 (USD MILLION)
CHART. 21. GLOBAL TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, BY END-USER, 2020-2026 (USD MILLION)
CHART. 22. GLOBAL TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE FOR ACADEMIC & RESEARCH INSTITUTES, BY GEOGRAPHY, 2020-2026 (USD MILLION)
CHART. 23. GLOBAL TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY GEOGRAPHY, 2020-2026 (USD MILLION)
CHART. 24. GLOBAL TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, BY GEOGRAPHY, 2020-2026 (USD MILLION)
CHART. 25. NORTH AMERICA TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, BY COUNTRY, 2020-2026 (USD MILLION)
CHART. 26. NORTH AMERICA TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, BY PRODUCT, 2020-2026 (USD MILLION)
CHART. 27. NORTH AMERICA TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, BY APPLICATION, 2020-2026 (USD MILLION)
CHART. 28. NORTH AMERICA TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, BY METHOD, 2020-2026 (USD MILLION)
CHART. 29. NORTH AMERICA TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, BY END-USER, 2020-2026 (USD MILLION)
CHART. 30. U.S TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, BY PRODUCT, 2020-2026 (USD MILLION)
CHART. 31. U.S TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, BY APPLICATION, 2020-2026 (USD MILLION)
CHART. 32. U.S TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, BY METHOD, 2020-2026 (USD MILLION)
CHART. 33. U.S TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, BY END-USER, 2020-2026 (USD MILLION)
CHART. 34. CANADA TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, BY PRODUCT, 2020-2026 (USD MILLION)
CHART. 35. CANADA TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, BY APPLICATION, 2020-2026 (USD MILLION)
CHART. 36. CANADA TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, BY METHOD, 2020-2026 (USD MILLION)
CHART. 37. CANADA TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, BY END-USER, 2020-2026 (USD MILLION)
CHART. 38. EUROPE TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, BY COUNTRY, 2020-2026 (USD MILLION)
CHART. 39. EUROPE TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, BY PRODUCT, 2020-2026 (USD MILLION)
CHART. 40. EUROPE TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, BY APPLICATION, 2020-2026 (USD MILLION)
CHART. 41. EUROPE TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, BY METHOD, 2020-2026 (USD MILLION)
CHART. 42. EUROPE TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, BY END-USER, 2020-2026 (USD MILLION)
CHART. 43. GERMANY TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, BY PRODUCT, 2020-2026 (USD MILLION)
CHART. 44. GERMANY TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, BY APPLICATION, 2020-2026 (USD MILLION)
CHART. 45. GERMANY TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, BY METHOD, 2020-2026 (USD MILLION)
CHART. 46. GERMANY TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, BY END-USER, 2020-2026 (USD MILLION)
CHART. 47. U.K TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, BY PRODUCT, 2020-2026 (USD MILLION)
CHART. 48. U.K TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, BY APPLICATION, 2020-2026 (USD MILLION)
CHART. 49. U.K TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, BY METHOD, 2020-2026 (USD MILLION)
CHART. 50. U.K TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, BY END-USER, 2020-2026 (USD MILLION)
CHART. 51. ROE TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, BY PRODUCT, 2020-2026 (USD MILLION)
CHART. 52. ROE TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, BY APPLICATION, 2020-2026 (USD MILLION)
CHART. 53. ROE TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, BY METHOD, 2020-2026 (USD MILLION)
CHART. 54. ROE TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, BY END-USER, 2020-2026 (USD MILLION)
CHART. 55. ASIA PACIFIC TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, BY COUNTRY, 2020-2026 (USD MILLION)
CHART. 56. ASIA PACIFIC TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, BY PRODUCT, 2020-2026 (USD MILLION)
CHART. 57. ASIA PACIFIC TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, BY APPLICATION, 2020-2026 (USD MILLION)
CHART. 58. ASIA PACIFIC TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, BY METHOD, 2020-2026 (USD MILLION)
CHART. 59. ASIA PACIFIC TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, BY END-USER, 2020-2026 (USD MILLION)
CHART. 60. CHINA TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, BY PRODUCT, 2020-2026 (USD MILLION)
CHART. 61. CHINA TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, BY APPLICATION, 2020-2026 (USD MILLION)
CHART. 62. CHINA TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, BY METHOD, 2020-2026 (USD MILLION)
CHART. 63. CHINA TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, BY END-USER, 2020-2026 (USD MILLION)
CHART. 64. JAPAN TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, BY PRODUCT, 2020-2026 (USD MILLION)
CHART. 65. JAPAN TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, BY APPLICATION, 2020-2026 (USD MILLION)
CHART. 66. JAPAN TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, BY METHOD, 2020-2026 (USD MILLION)
CHART. 67. JAPAN TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, BY END-USER, 2020-2026 (USD MILLION)
CHART. 68. REST OF ASIA PACIFIC TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, BY PRODUCT, 2020-2026 (USD MILLION)
CHART. 69. REST OF ASIA PACIFIC TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, BY APPLICATION, 2020-2026 (USD MILLION)
CHART. 70. REST OF ASIA PACIFIC TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, BY METHOD, 2020-2026 (USD MILLION)
CHART. 71. REST OF ASIA PACIFIC TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, BY END-USER, 2020-2026 (USD MILLION)
CHART. 72. REST OF WORLD TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, BY PRODUCT, 2020-2026 (USD MILLION)
CHART. 73. REST OF WORLD TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, BY APPLICATION, 2020-2026 (USD MILLION)
CHART. 74. REST OF WORLD TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, BY METHOD, 2020-2026 (USD MILLION)
CHART. 75. REST OF WORLD TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, BY END-USER, 2020-2026 (USD MILLION)
CHART. 1. GLOBAL TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, BY PRODUCT, 2020-2026 (USD MILLION)
CHART. 2. GLOBAL TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE FOR REAGENTS, BY GEOGRAPHY, 2020-2026 (USD MILLION)
CHART. 3. GLOBAL TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE FOR EQUIPMENT, BY GEOGRAPHY, 2020-2026 (USD MILLION)
CHART. 4. GLOBAL TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, BY APPLICATION, 2020-2026 (USD MILLION)
CHART. 5. GLOBAL TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE FOR BIOMEDICAL RESEARCH, BY GEOGRAPHY, 2020-2026 (USD MILLION)
CHART. 6. GLOBAL TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE FOR GENE EXPRESSION STUDIES, BY GEOGRAPHY, 2020-2026 (USD MILLION)
CHART. 7. GLOBAL TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE FOR CANCER RESEARCH, BY GEOGRAPHY, 2020-2026 (USD MILLION)
CHART. 8. GLOBAL TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE FOR TRANSGENIC MODEL, BY GEOGRAPHY, 2020-2026 (USD MILLION)
CHART. 9. GLOBAL TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE FOR PROTEIN PRODUCTION, BY GEOGRAPHY, 2020-2026 (USD MILLION)
CHART. 10. GLOBAL TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE FOR THERAPEUTIC DELIVERY, BY GEOGRAPHY, 2020-2026 (USD MILLION)
CHART. 11. GLOBAL TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, BY METHOD, 2020-2026 (USD MILLION)
CHART. 12. GLOBAL TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE FOR BIOCHEMICAL, BY GEOGRAPHY, 2020-2026 (USD MILLION)
CHART. 13. GLOBAL TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE FOR CALCIUM PHOSPHATE, BY GEOGRAPHY, 2020-2026 (USD MILLION)
CHART. 14. GLOBAL TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE FOR LIPOFECTION, BY GEOGRAPHY, 2020-2026 (USD MILLION)
CHART. 15. GLOBAL TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE FOR DEAE-DEXTRAN, BY GEOGRAPHY, 2020-2026 (USD MILLION)
CHART. 16. GLOBAL TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE FOR DENDRIMERS, BY GEOGRAPHY, 2020-2026 (USD MILLION)
CHART. 17. GLOBAL TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE FOR PHYSICAL, BY GEOGRAPHY, 2020-2026 (USD MILLION)
CHART. 18. GLOBAL TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE FOR ELECTROPORATION, BY GEOGRAPHY, 2020-2026 (USD MILLION)
CHART. 19. GLOBAL TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE FOR NUCLEOFECTION, BY GEOGRAPHY, 2020-2026 (USD MILLION)
CHART. 20. GLOBAL TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE FOR OTHERS, BY GEOGRAPHY, 2020-2026 (USD MILLION)
CHART. 21. GLOBAL TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, BY END-USER, 2020-2026 (USD MILLION)
CHART. 22. GLOBAL TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE FOR ACADEMIC & RESEARCH INSTITUTES, BY GEOGRAPHY, 2020-2026 (USD MILLION)
CHART. 23. GLOBAL TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY GEOGRAPHY, 2020-2026 (USD MILLION)
CHART. 24. GLOBAL TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, BY GEOGRAPHY, 2020-2026 (USD MILLION)
CHART. 25. NORTH AMERICA TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, BY COUNTRY, 2020-2026 (USD MILLION)
CHART. 26. NORTH AMERICA TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, BY PRODUCT, 2020-2026 (USD MILLION)
CHART. 27. NORTH AMERICA TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, BY APPLICATION, 2020-2026 (USD MILLION)
CHART. 28. NORTH AMERICA TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, BY METHOD, 2020-2026 (USD MILLION)
CHART. 29. NORTH AMERICA TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, BY END-USER, 2020-2026 (USD MILLION)
CHART. 30. U.S TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, BY PRODUCT, 2020-2026 (USD MILLION)
CHART. 31. U.S TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, BY APPLICATION, 2020-2026 (USD MILLION)
CHART. 32. U.S TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, BY METHOD, 2020-2026 (USD MILLION)
CHART. 33. U.S TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, BY END-USER, 2020-2026 (USD MILLION)
CHART. 34. CANADA TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, BY PRODUCT, 2020-2026 (USD MILLION)
CHART. 35. CANADA TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, BY APPLICATION, 2020-2026 (USD MILLION)
CHART. 36. CANADA TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, BY METHOD, 2020-2026 (USD MILLION)
CHART. 37. CANADA TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, BY END-USER, 2020-2026 (USD MILLION)
CHART. 38. EUROPE TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, BY COUNTRY, 2020-2026 (USD MILLION)
CHART. 39. EUROPE TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, BY PRODUCT, 2020-2026 (USD MILLION)
CHART. 40. EUROPE TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, BY APPLICATION, 2020-2026 (USD MILLION)
CHART. 41. EUROPE TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, BY METHOD, 2020-2026 (USD MILLION)
CHART. 42. EUROPE TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, BY END-USER, 2020-2026 (USD MILLION)
CHART. 43. GERMANY TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, BY PRODUCT, 2020-2026 (USD MILLION)
CHART. 44. GERMANY TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, BY APPLICATION, 2020-2026 (USD MILLION)
CHART. 45. GERMANY TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, BY METHOD, 2020-2026 (USD MILLION)
CHART. 46. GERMANY TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, BY END-USER, 2020-2026 (USD MILLION)
CHART. 47. U.K TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, BY PRODUCT, 2020-2026 (USD MILLION)
CHART. 48. U.K TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, BY APPLICATION, 2020-2026 (USD MILLION)
CHART. 49. U.K TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, BY METHOD, 2020-2026 (USD MILLION)
CHART. 50. U.K TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, BY END-USER, 2020-2026 (USD MILLION)
CHART. 51. ROE TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, BY PRODUCT, 2020-2026 (USD MILLION)
CHART. 52. ROE TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, BY APPLICATION, 2020-2026 (USD MILLION)
CHART. 53. ROE TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, BY METHOD, 2020-2026 (USD MILLION)
CHART. 54. ROE TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, BY END-USER, 2020-2026 (USD MILLION)
CHART. 55. ASIA PACIFIC TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, BY COUNTRY, 2020-2026 (USD MILLION)
CHART. 56. ASIA PACIFIC TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, BY PRODUCT, 2020-2026 (USD MILLION)
CHART. 57. ASIA PACIFIC TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, BY APPLICATION, 2020-2026 (USD MILLION)
CHART. 58. ASIA PACIFIC TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, BY METHOD, 2020-2026 (USD MILLION)
CHART. 59. ASIA PACIFIC TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, BY END-USER, 2020-2026 (USD MILLION)
CHART. 60. CHINA TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, BY PRODUCT, 2020-2026 (USD MILLION)
CHART. 61. CHINA TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, BY APPLICATION, 2020-2026 (USD MILLION)
CHART. 62. CHINA TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, BY METHOD, 2020-2026 (USD MILLION)
CHART. 63. CHINA TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, BY END-USER, 2020-2026 (USD MILLION)
CHART. 64. JAPAN TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, BY PRODUCT, 2020-2026 (USD MILLION)
CHART. 65. JAPAN TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, BY APPLICATION, 2020-2026 (USD MILLION)
CHART. 66. JAPAN TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, BY METHOD, 2020-2026 (USD MILLION)
CHART. 67. JAPAN TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, BY END-USER, 2020-2026 (USD MILLION)
CHART. 68. REST OF ASIA PACIFIC TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, BY PRODUCT, 2020-2026 (USD MILLION)
CHART. 69. REST OF ASIA PACIFIC TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, BY APPLICATION, 2020-2026 (USD MILLION)
CHART. 70. REST OF ASIA PACIFIC TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, BY METHOD, 2020-2026 (USD MILLION)
CHART. 71. REST OF ASIA PACIFIC TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, BY END-USER, 2020-2026 (USD MILLION)
CHART. 72. REST OF WORLD TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, BY PRODUCT, 2020-2026 (USD MILLION)
CHART. 73. REST OF WORLD TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, BY APPLICATION, 2020-2026 (USD MILLION)
CHART. 74. REST OF WORLD TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, BY METHOD, 2020-2026 (USD MILLION)
CHART. 75. REST OF WORLD TRANSFECTION REAGENTS AND EQUIPMENT MARKET VALUE, BY END-USER, 2020-2026 (USD MILLION)
